Stimulator, Low Electric Field, Tumor Treatment
NZK is the FDA product code for Stimulator, Low Electric Field, Tumor Treatment, a class III device type. FDA's definition for this code reads: "Intended to treat tumors by application of low electic fields and indicated for treatment of recurrent glioblastoma multiforme (gbm) in patients who have received maximum standard therapy with continued disease progress, as defined by tumor growth or decline in neurological status". As of , FDA records hold no 510(k) clearances under this code and no recalls.
Classification record
- Product code
- NZK
- Device name
- Stimulator, Low Electric Field, Tumor Treatment
- FDA definition
- Intended to treat tumors by application of low electic fields and indicated for treatment of recurrent glioblastoma multiforme (gbm) in patients who have received maximum standard therapy with continued disease progress, as defined by tumor growth or decline in neurological status.
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- Yes
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 0
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
